Yersinia pestis infection pathophysiology
Yersinia pestis infection Microchapters |
Differentiating Yersinia Pestis Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Yersinia pestis infection pathophysiology On the Web |
American Roentgen Ray Society Images of Yersinia pestis infection pathophysiology |
Risk calculators and risk factors for Yersinia pestis infection pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editors-In-Chief: Esther Lee, M.A.; Rim Halaby, M.D. [2]; João André Alves Silva, M.D. [3]
Overview
The route of infection (fleabite or aerosolized particles) classifies plague into: bubonic, pulmonic or septicemic. Yersinia pestis produces several virulence factors which are responsible for: evasion of the immune system, survival of the bacteria inside host cells, and infectious mechanisms, such as: degradation of extracellular proteins, production of endotoxins and inhibition of platelet aggregation. Y. pestis aggregates in different tissues, causing inflammation and necrosis, that are responsible for some of the clinical findings of plague: lymphadenopathy and abscesses (bubonic); bacteremia and sepsis (septicemic) and pneumonia and ARDS (pulmonic).
Pathogenesis
According to the route of infection, the plague may be divided into:[1]
Bubonic plague
- The most frequent type of plague.
- Commonly occurs within 2 to 6 days, after a fleabite. The fleabite allows for the bacteria to pass the skin barrier.
- On the inoculation site there may be an ulcer, papule, vesicle or eschar.
- Local cutaneous proliferation, usually not clinically evident, occurs after inoculation.
- The infection spreads via the lymphatics to the regional lymph nodes causing inflammation and swelling in one or several nodes. This will cause regional lymphadenopathy and abscesses., often called buboes. Buboes may occur in any regional lymph node sites including:[2]
- Inguinal
- Axillary
- Supraclavicular
- Cervical
- Post-auricular
- Epitrochlear
- Popliteal
- Pharyngeal
- Deeper nodes (intra-abdominal or intrathoracic) may be involved by lymphatic or hematogenous extension.[2]
- Some virulence factors, allow Y. pestis to avoid phagocytosis by the host's immune system.[1]
- In the lymph nodes, Yersinia replicates and forms aggregates of bacteria in necrotic lesions. This leads to the destruction of the lymph node, and consequently to the spread of bacteria through the bloodstream, causing endotoxemia, bacteremia and septicemia.[1]
Pulmonic Plague
- Results from the inhalation of droplets infected with Y. pestis. The bacteria initially infect the oropharynx through respiratory droplets, expelled during coughing or sneezing by a patient (or animal) with pulmonic plague, or by ingestion of undercooked or raw tissues of an infected animal.[1]
- The incubation period is usually 1-3 days.[1]
- Yersinia pestis expresses a plasminogen activator that is an important virulence factor for pneumonic plague, and that might degrade on blood clots to facilitate systematic invasion.[3]
- Most severe type of plague, commonly leading to death with 24 hours of illness onset.[1][4][5][6]
Septicemic plague
- May be classified in primary or secondary septicemic plague:[1]
- Primary Septicemic Plague:
- Cutaneous exposure to the bacteria, without lymphadenopathy, followed by systemic bacteremia.
- Althought it affects all age groups, elderly are more commonly affected.
- Secondary Septicemic Plague:
- Bacterial spread, from an initial focus of infection, such as the skin (bubonic plague) or the lungs (pulmonic plague).
- Simillar clinical presentation to other gram-negative septicemias.
- Presence of rapidly replicating gram-negative bacilli in the bloodstream initiates a self-perpetuating immunological cascade, typically linked to the host response to the bacterial endotoxin.
- The host response may result in a wide spectrum of pathological events including disseminated intravascular coagulopathy (DIC), multiple organ failure, and adult respiratory distress syndrome (ARDS).
Meningeal plague
- A complication often associated with delayed or inappropriate antibiotic therapy.
- More common in patients with axillary (as opposed to inguinal) buboes.
Virulence Factors
Yersinia pestis produces several risk factors that allow it to evade the host's immune system and cause infection. These virulence factors include:[1]
Phospholipase D
- Survival inside the flea
V antigen and W antigen
- Phagocytosis resistance
Low-calcium-response plasmid
- Activation of Yersinia pestis outer proteins
- Activation of the V-antigen (low calcium environments)
Hemin storage system
- Pigmentation marker in laboratory
- Survival inside phagocytes
- Stimulates uptake of bacteria by eukaryotic cells
Plasminogen activator
- Degradation of extracellular proteins, such as fibrin, thereby facilitating bacterial spread
Lipopolysaccharide endotoxin
- Responsible for endotoxic shock
Yersinia outer proteins (Yops)
- Inhibitor of:
F1 antigen
- Antiphagocytic factor
- Target of immunologic] tests for diagnosis
- Initiates humoral response
Evasion of the Immune System
Anti-phagocytic Antigens
Many of the bacteria's virulence factors are anti-phagocytic in nature. Two important antiphagocytic antigens, named F1 (Fraction 1) and V or LcrV, are both important for virulence. These antigens are produced by the bacterium at normal human body temperature. Furthermore, Yersinia pestis survives and produces F1 and V antigens while it is residing within white blood cells such as monocytes, but not in neutrophils. Natural or induced immunity is achieved by the production of specific opsonic antibodies against F1 and V antigens; antibodies against F1 and V induce phagocytosis by neutrophils.[7]
Type III Secretion System (T3SS)
The Type III secretion system (T3SS) allows Yersinia pestis to inject proteins into macrophages and other immune cells. These T3SS-injected proteins are called Yops (Yersinia Outer Proteins) and include Yop B/D, which form pores in the host cell membrane and have been linked to cytolysis.
The YopO, YopH, YopM, YopT, YopJ, and YopE are injected into the cytoplasm of host cells via T3SS, into the pore created in part by YopB and YopD.[8]
The injected Yop proteins limit phagocytosis and [[cell signaling] pathways]] important in the innate immune system. In addition, some Yersinia pestis strains are capable of interfering with immune signaling (e.g., by preventing the release of some cytokines).
Yersinia Outer Proteins
- YopH - Protein tyrosine phosphatase that contributes to the ability of Yersinia pestis to evade the immune system.[9] In macrophages, YopH dephosphorylates p130Cas, Fyb (Fyn binding protein) SKAP-HOM and Pyk, a tyrosine kinase homologous to FAK.
- YopH also binds the p85 subunit of phosphoinositide 3-kinase, the Gab1, the Gab2 adapter proteins, and the Vav guanine nucleotide exchange factor.
- YopE - Functions as a GTPase activating protein for members of the Rho family of GTPases such as RAC1.
- YopT - Cysteine protease that inhibits RhoA by removing the isoprenyl group. It has been proposed that YopE and YopT may function to limit YopB/D-induced cytolysis.[10] This might limit the function of YopB/D to create the pores used for Yop insertion into host cells. It may also prevent YopB/D-induced rupture of host cells, and the release of cell contents that would attract and stimulate immune system responses.
- YopJ - Acetyltransferase that binds to a conserved α-helix of MAPK kinases.[11]
- Responsible for acetylation of MAPK at serines and threonine groups, which are normally phosphorylated during activation of the MAP kinase cascade.[12][13] YopJ is activated in eukaryotic cells by interaction with target cell Phytic acid (IP6).[14] This disruption of host cell protein kinase activity causes apoptosis of macrophages.
- This mechanism has been proposed to play a role in the establishment of infection, and evasion of the host immune response, by the bacteria.
- YopO - Protein kinase, also known as Yersinia protein kinase A (YpkA), is a potent inducer of human macrophage apoptosis.[15]
Genetics
Yersinia pestis expresses the yadBC gene, which is similar to adhesins in other Yersinia species, allowing for adherence and invasion of epithelial cells.[16]
Transmission
Transmission of Y. pestis may occur through:[17]
- Droplet contact – coughing or sneezing on another person
- Direct physical contact – touching an infected person, including sexual contact
- Indirect contact – usually by touching soil contamination or a contaminated surface
- Airborne transmission – if the microorganism can remain in the air for long periods
- Fecal-oral transmission – usually from contaminated food or water sources
- Vector borne transmission – carried by insects or other animals
Unlike other types of plague, the pneumonic type can be transmitted from person to person. Pneumonic plague affects the lungs and is transmitted when a person breathes in Y. pestis particles in the air.
Bubonic plague is transmitted through the bite of an infected flea or exposure to infected material through a break in the skin.
Flea Bites
Plague bacteria are most often transmitted by the bite of an infected flea. During plague epizootics, many rodents die, causing hungry fleas to seek other sources of blood. People and animals that visit places where rodents have recently died from plague, are at risk of being infected from flea bites. Dogs and cats may also bring plague-infected fleas into the home. Flea bite exposure may result in primary bubonic plague or septicemic plague.
This way of transmission distinguishes Yersinia pestis from other enterobacteriaceae such as Yersinia pseudotuberculosis.[1]
Contact with Contaminated Fluid or Tissue
Humans can become infected when handling tissue or body fluids of a plague-infected animal. For example, a hunter skinning a rabbit or other infected animal without using proper precautions could become infected with plague bacteria. This form of exposure most commonly results in bubonic plague or septicemic plague.
Infectious Droplets
When a person has plague pneumonia, they may cough droplets containing the plague bacteria into air. If these bacteria-containing droplets are breathed in by another person, they can cause pneumonic plague.
Typically this requires direct and close contact with the person with pneumonic plague. Transmission of these droplets is the only way that plague can spread between people. This type of spread has not been documented in the United States since 1924, but still occurs with some frequency in developing countries.
Cats are particularly susceptible to plague, and can be infected by eating infected rodents. Sick cats pose a risk of transmitting infectious plague droplets to their owners or to veterinarians. Several cases of human plague have occurred in the United States in recent decades as a result of contact with infected cats.
Gross Pathology
Bubonic Plague
Common presentation includes a skin lesion, that may be a papule, vesicle, ulcer or eschar on the site of the bite, and enlarged regional lymph nodes. The "buboes" may measure from 1 to 10 cm. There may also be deeper enlarged lymph nodes.[1]
Pulmonic Plague
Commonly occurs with pulmonary lobe involvement, progressing into bilateral pneumonia, pleurisy, cavitations, potentially culminating in ARDS.[1]
Septicemic Plague
This type of plague commonly leads to small vessel thrombosis, which is responsible for the necrosis of extremities, such as fingers, toes and tip of the nose. These manifestations may occur in advanced disease.[1]
Microscopic Pathology
Studies in Y. pestis-infected cats revealed similar histological changes to those verified in humans. Common microscopic findings include:[18]
- Aggregations of bacteria in lymphoid tissues, and lungs (cases of pneumonic plague).
- Lymph node necrosupporative inflammation.
- Identification of the bacteria in infected sites.
- Individuals infected orally have more lesions on head and neck lymph nodes.
Gallery
Gross Pathology
-
Necropsy of a rock squirrel, Spermophilus variegatus, formerly known as Citellus variegatus, which was afflicted with the pneumonic hemorrhagic plague. Note the presence of hemorrhagic blood that had been expelled from the animal’s nares, which had been the result of pulmonic hemorrhage. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Necropsy of a rock squirrel, Spermophilus variegatus, exposure of the animal’s abdominal viscera revealed the presence of a massive hemorrhagic reaction, which was due to a Yersinia pestis infection, the bacteria responsible for causing plague Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Necropsy of a rock squirrel, Spermophilus variegatus, exposure of the animal’s abdominal viscera revealed the presence of a massive hemorrhagic reaction, which was due to a Yersinia pestis infection, the bacteria responsible for causing plague. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Necropsy of a rock squirrel, Spermophilus variegatus, exposure of the animal’s abdominal viscera revealed the presence of a massive hemorrhagic reaction, which was due to a Yersinia pestis infection, the bacteria responsible for causing plague. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Necropsy of a rock squirrel, Spermophilus variegatus, exposure of the animal’s abdominal viscera revealed the presence of a massive hemorrhagic reaction, which was due to a Yersinia pestis infection, the bacteria responsible for causing plague Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
Microscopic Pathology
-
Photomicrograph depicts a blood smear that revealed the presence of Gram-negative Yersinia pestis plague bacteria Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Magnification of 500X, this hematoxylin and eosin-stained (H&E) lung tissue sample revealing the histopathologic changes indicative of what was diagnosed as a case of fatal human plague from the country of Nepal. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Low magnification of 125X, this hematoxylin and eosin-stained lung tissue sample revealed the histopathologic changes indicative of what was diagnosed as a case of fatal human plague from the country of Nepal. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
High magnification of 1200X, this Brown and Brenn-stained lung tissue sample revealing the histopathologic changes indicative of what was diagnosed as a case of fatal human plague from the country of Nepal. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Magnification of 500X, this hematoxylin and eosin-stained splenic tissue sample revealing the histopathologic changes indicative of what was diagnosed as a case of fatal human plague from the country of Nepal Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Photomicrograph depicting the histopathologic changes in lung tissue in a case of fatal human plague pneumonia; Mag. 160X Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Photomicrograph depicting the histopathologic changes in splenic tissue in a case of fatal human plague; Mag. 400X Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Micrograph of a blood smear containing Yersinia pestis plague bacteria.Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Photomicrograph of lung tissue revealing Yersinia pestis organisms Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Yersinia pestis, Gram-negative bacillus, 1000x Magnification Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Yersinia pestis, Gram-negative bacillus Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Yersinia pestis, Gram-negative bacillus, 1000x Magnification Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of lymph node in fatal human plague Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of pancreas in fatal human plague Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of lung in fatal human plagueAdapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of lung in a case of fatal human plague pneumonia.Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Low magnification of 96X, this hematoxylin-eosin stained (H&E) photomicrograph revealing some of the histopathologic changes seen in a lymph node tissue sample in a case of fatal human plague. Note the medullary necrosis accompanied by fluid due to the presence of Yersinia pestis bacteria Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of lymph node in fatal human plague. Focal cortical necrosis. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of liver in fatal human plague. Focal hepatocellular necrosis adjacent to thrombosis. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of liver in fatal human plague. Necrosis and thrombosis of portal vein. Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of lung in fatal human plague. Area of marked fibrinopurulent pneumonia Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
Histopathology of spleen in fatal human plague. Necrosis and Yersinia pestis Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
-
At a relatively-low magnification of 160X, this hematoxylin and eosin-stained splenic tissue sample revealed the histopathologic changes indicative of vasculitis and thrombosis associated with what was diagnosed as a case of fatal human plague Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[19]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Koirala, Janak (2006). "Plague: Disease, Management, and Recognition of Act of Terrorism". Infectious Disease Clinics of North America. 20 (2): 273–287. doi:10.1016/j.idc.2006.02.004. ISSN 0891-5520.
- ↑ 2.0 2.1 Plague Manual: Epidemiology, Distribution, Surveillance. World Health Organization. Communicable Disease Surveillance and Response and Control. WHO/CDS/CSR/EDC/99.2
- ↑ Lathem WW, Price PA, Miller VL, Goldman WE (2007). "A plasminogen-activating protease specifically controls the development of primary pneumonic plague". Science. 315 (5811): 509–13. doi:10.1126/science.1137195. PMID 17255510.
- ↑ "Plague manual--epidemiology, distribution, surveillance and control". Wkly Epidemiol Rec. 74 (51–52): 447. 1999. PMID 10635759.
- ↑ Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A; et al. (2004). "Bichat guidelines for the clinical management of plague and bioterrorism-related plague". Euro Surveill. 9 (12): E5–6. PMID 15677847.
- ↑ Cleri DJ, Vernaleo JR, Lombardi LJ, Rabbat MS, Mathew A, Marton R; et al. (1997). "Plague pneumonia disease caused by Yersinia pestis". Semin Respir Infect. 12 (1): 12–23. PMID 9097371.
- ↑ Salyers AA, Whitt DD (2002). Bacterial Pathogenesis: A Molecular Approach (2nd ed.). ASM Press. pp. 207-12.
- ↑ Viboud GI, Bliska JB (2005). "Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis". Annu. Rev. Microbiol. 59: 69–89. doi:10.1146/annurev.micro.59.030804.121320. PMID 15847602.
- ↑ de la Puerta ML, Trinidad AG, del Carmen Rodríguez M, Bogetz J, Sánchez Crespo M, Mustelin T, Alonso A, Bayón Y (2009). Bozza, Patricia, ed. "Characterization of New Substrates Targeted By Yersinia Tyrosine Phosphatase YopH". PLoS ONE. 4 (2): e4431. doi:10.1371/journal.pone.0004431. PMC 2637541. PMID 19221593. Unknown parameter
|month=
ignored (help) - ↑ Mejía E, Bliska JB, Viboud GI (2009). "Yersinia Controls Type III Effector Delivery into Host Cells by Modulating Rho Activity". PLoS ONE. 4 (2): e4431. doi:10.1371/journal.ppat.0040003. PMC 2186360. PMID 18193942. Unknown parameter
|month=
ignored (help) - ↑ Hao YH, Wang Y, Burdette D, Mukherjee S, Keitany G, Goldsmith E, Orth K (2008). Kobe, Bostjan, ed. "Structural Requirements for Yersinia YopJ Inhibition of MAP Kinase Pathways". PLoS ONE. 2 (3): e1375. doi:10.1371/journal.pone.0001375. PMC 2147050. PMID 18167536. Unknown parameter
|month=
ignored (help) - ↑ Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K (2006). "Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation". Science. 312 (5777): 1211–1214. doi:10.1126/science.1126867. PMID 16728640. Unknown parameter
|month=
ignored (help) - ↑ Mittal R, Peak-Chew S-Y, McMahon HT (2006). "Acetylation of MEK2 and IκB kinase (IKK) activation loop residues by YopJ inhibits signaling". Proc. Natl. Acad. Sci. USA. 103 (49): 18574–18579. doi:10.1073/pnas.0608995103. PMC 1654131. PMID 17116858. Unknown parameter
|month=
ignored (help) - ↑ Mittal R, Peak-Chew SY, Sade RS, Vallis Y, McMahon HT (2010). "The Acetyltransferase Activity of the Bacterial Toxin YopJ of Yersinia Is Activated by Eukaryotic Host Cell Inositol Hexakisphosphate". J Biol Chem. 285 (26): 19927–34. doi:10.1074/jbc.M110.126581. PMC 2888404. PMID 20430892.
- ↑ Park H, Teja K, O'Shea JJ, Siegel RM (2007). "The Yersinia effector protein YpkA induces apoptosis independently of actin depolymerization". J Immunol. 178 (10): 6426–6434. PMID 17475872. Unknown parameter
|month=
ignored (help) - ↑ Forman S, Wulff CR, Myers-Morales T, Cowan C, Perry RD, Straley SC (2008). "yadBC of Yersinia pestis, a New Virulence Determinant for Bubonic Plague". Infect. Immun. 76 (2): 578–87. doi:10.1128/IAI.00219-07. PMC 2223446. PMID 18025093.
- ↑ Plague Manual: Epidemiology, Distribution, Surveillance and Control, pp. 9 and 11. WHO/CDS/CSR/EDC/99.2
- ↑ Watson RP, Blanchard TW, Mense MG, Gasper PW (2001). "Histopathology of experimental plague in cats". Vet Pathol. 38 (2): 165–72. PMID 11280372.
- ↑ 19.00 19.01 19.02 19.03 19.04 19.05 19.06 19.07 19.08 19.09 19.10 19.11 19.12 19.13 19.14 19.15 19.16 19.17 19.18 19.19 19.20 19.21 19.22 19.23 19.24 19.25 19.26 19.27 "Public Health Image Library (PHIL), Centers for Disease Control and Prevention".